EUVIMEDEUVIMED entdecken
Crossref

Tolerability and efficacy of two synergistic ratios of oral morphine and oxycodone combinations versus morphine in patients with chronic noncancer pain

Felix A. De la Iglesia, MD, Gary W. Pace, PhD, Gary L. W. G. Robinson, PhD, Nuo-Yu Huang, MD, PhD, Warren Stern, PhD, Patricia Richards und 2 weitere

Journal of Opioid Management · 2012

DOI: 10.5055//jom.2012.0101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Opioid Management, 2012. Verfasst von Felix A. De la Iglesia und 13 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Analgesic synergy and improved tolerability have been reported for flexible dose morphine and oxycodone combinations. This report describes two studies with similar double-blind, randomized, 7-day crossover designs (up to 7 days per arm) conducted to 1) explore the analgesic and safety benefit of fixed ratio of morphine (M) and oxycodone (O) combinations (MOX) and 2) define the optimal ratio for morphine and oxycodone combination.

Setting

Clinical study centers in Australia.Patients: Patients with chronic noncancer pain.

Intervention

Eligible patients were randomly assigned to receive flexible doses of either M or fixed ratio of MOX (M3:O2 in study A; M1:O2 in study B). The starting doses of M or MOX were the morphine equivalent doses (MEDs) converted from the analgesics received before entering double-blind treatment. At each crossover period, the doses were titrated to achieve analgesia at steady state, which was defined as when the same total daily dose (±10 percent) had been given consecutively for 3 days.Main outcome measure: The primary endpoint was the study medication dose (MED), which produced adequate pain control at steady state.

Results

Analgesic synergy in MOX was observed in both studies. On an MED basis, 61.6 percent (study A, M:O = 3:2) or 46.8 percent (study B, M:O = 1:2) more MED were needed for M monotherapy to achieve steady-state pain control when compared with MOX. Patient tolerability profiles were also generally better in the MOX groups.

Conclusion

A 3:2 or1:2 fixed ratio combination of morphine and oxycodone (MOX) produced analgesic synergy and a tolerability profile improvement in patients with chronic noncancer pain.

Zitieren

APA

Iglesia, F. A. D. L., MD, Pace, G. W., PhD, Robinson, G. L. W. G., PhD, Huang, N., MD, PhD, Stern, W., PhD, Richards, P., MD, & PhD (2012). Tolerability and efficacy of two synergistic ratios of oral morphine and oxycodone combinations versus morphine in patients with chronic noncancer pain. Journal of Opioid Management. https://doi.org/10.5055//jom.2012.0101

Vancouver

Iglesia FADL, MD, Pace GW, PhD, Robinson GLWG, PhD, et al. Tolerability and efficacy of two synergistic ratios of oral morphine and oxycodone combinations versus morphine in patients with chronic noncancer pain. Journal of Opioid Management. 2012. doi:10.5055//jom.2012.0101

BibTeX
@article{Iglesia2012,
  author = {Iglesia, Felix A. De la and MD and Pace, Gary W. and PhD and Robinson, Gary L. W. G. and PhD and Huang, Nuo-Yu and MD and PhD and Stern, Warren and PhD and Richards, Patricia and MD and PhD},
  title = {Tolerability and efficacy of two synergistic ratios of oral morphine and oxycodone combinations versus morphine in patients with chronic noncancer pain},
  journal = {Journal of Opioid Management},
  year = {2012},
  doi = {10.5055//jom.2012.0101}
}
Kostenlos starten →